Martha Wadleigh MD

Oncology•Boston, MA

Hematologic Oncology

Assistant Professor of Medicine, Dana-Farber Cancer Institute

Join to View Full Profile

44 Binney St# 1B25Boston, MA 02115
Phone+1 617-632-6685
Fax+1 617-582-8202

Education & Training

Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2001 - 2004
Duke University HospitalResidency, Internal Medicine, 1998 - 2001
Duke University School of MedicineClass of 1998

Certifications & Licensure

MA State Medical License 2004 - 2025
NH State Medical License 2024 - 2024
NC State Medical License 1998 - 2001
American Board of Internal Medicine Hematology

Clinical Trials

Vaccine Therapy and Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia Start of enrollment: 2005 Sep 01
Completed
Phase 1
Study of Cordycepin Plus Pentostatin in Patients With Refractory TdT-Positive Leukemia Start of enrollment: 2008 Jun 01
Unknown status
Phase 1, Phase 2
A Phase 1/2 Study of Oral SB1518 in Subjects With Chronic Idiopathic Myelofibrosis Start of enrollment: 2008 Aug 01
Completed
Phase 1, Phase 2
Safety and Efficacy Study of CYT387 in Primary Myelofibrosis (PMF) or Post-polycythemia Vera (PV) or Post-essential Thrombocythemia (ET) Start of enrollment: 2009 Nov 01
Completed
Phase 1, Phase 2
Safety and Tolerability Study of Oral NS-018 in Patients With Primary Myelofibrosis (MF), Post-polycythemia Vera MF or Post-essential Thrombocythemia MF Start of enrollment: 2011 Jun 01
Completed
Phase 1, Phase 2
A Phase 1B Study to Investigate the Safety and Preliminary Efficacy for the Combination of Dasatinib Plus Nivolumab in Patients With Chronic Myeloid Leukemia Start of enrollment: 2014 Feb 07
Completed
Phase 1
Combination Merestinib and LY2874455 for Patients With Relapsed or Refractory Acute Myeloid Leukemia Start of enrollment: 2017 Aug 10
Completed
Phase 1
Join now to see all

Publications & Presentations

PubMed

1 citations
Asciminib plus dasatinib and prednisone for Philadelphia chromosome-positive acute leukemia.
Marlise R Luskin, Mark A Murakami, Julia Keating, Yael Flamand, Eric S Winer
Blood. 2025-02-06
1 citations
Venous thromboembolism in adolescents and young adults with acute lymphoblastic leukemia treated on a pediatric-inspired regimen.
Shai Shimony, Hari S Raman, Yael Flamand, Julia Keating, Jonathan D Paolino
Blood Cancer Journal. 2024-10-31
3 citations
Subunit-specific analysis of cohesin-mutant myeloid malignancies reveals distinct ontogeny and outcomes.
Johann-Christoph Jann, Christopher B Hergott, Marisa Winkler, Yiwen Liu, Benjamin Braun
Leukemia. 2024-09-01

Abstracts/Posters

Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical, Clinical, and Correlative Studies
Martha Wadleigh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
A Phase I Study of Asciminib (ABL001) in Combination with Dasatinib and Prednisone for Untreated BCR-ABL1-Positive ALL in Older Adults
Martha Wadleigh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
A Phase 1 Dose-Escalation Study of Adding Venetoclax to a Reduced Intensity Conditioning (RIC) Regimen Prior to Allogeneic Hematopoietic Cell Transplantation for Patie...
Martha Wadleigh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Real World Outcomes of Adult B-Cell Acute Lymphocytic Leukemia Patients Treated with Blinatumomab
Martha Wadleigh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Patient-Reported Outcome Results from the U.S. Life after Stopping TKIs (LAST) Study in Patients with Chronic Myeloid Leukemia
Martha Wadleigh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Clinical and Immunologic Activity of Ipilimumab Following Decitabine Priming in Post-Allogeneic Transplant and Transplant-Na¥ve Patients with Relapsed or Refractory My...
Martha Wadleigh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Real World Outcomes of Adult B-Cell Acute Lymphocytic Leukemia Patients Treated with Inotuzumab Ozogamicin
Martha Wadleigh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Sleep Disturbance Among Patients with Myelodysplastic Syndromes and Acute Leukemia
Martha Wadleigh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Join now to see all